Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel
NASDAQ:QUCY

Mainz Biomed Q4 2025 Earnings Report

$1.59 +0.07 (+4.61%)
As of 09/4/2026 04:00 PM Eastern
ProfileEarnings HistoryForecast

Mainz Biomed EPS Results

Actual EPS
-$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Mainz Biomed Revenue Results

Actual Revenue
$0.13 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Mainz Biomed Announcement Details

Quarter
Q4 2025
Date
3/31/2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Mainz Biomed Earnings Headlines

Quantum Cyber NV (QUCY)
September 4 at 2:59 PM  |  ru.investing.comhttps://ru.investing.com/equities/mainz-biomed-bv-financial-summary
Quantum Cyber Invites Qualified Foundries, and Prototype-Development Partners to Apply for Its Quantum-Photonic Antenna Manufacturing Program; Responses Due September 18, 2026
September 4 at 7:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/04/3356506/0/en/quantum-cyber-invites-qualified-foundries-and-prototype-development-partners-to-apply-for-its-quantum-photonic-antenna-manufacturing-program-responses-due-september-18-2026.html
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
 |  Altimetry (Ad)
Quantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense Platform
September 2 at 7:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/02/3355015/0/en/quantum-cyber-appoints-tzvi-lev-as-head-of-sales-middle-east-to-lead-gcc-commercial-expansion-of-its-autonomous-defense-platform.html
Quantum Cyber Completes Purchase and Installation of 80-Unit 3D Printing Drone Production Farm at Its Bridgeport, Connecticut Manufacturing Facility
August 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/31/3353204/0/en/quantum-cyber-completes-purchase-and-installation-of-80-unit-3d-printing-drone-production-farm-at-its-bridgeport-connecticut-manufacturing-facility.html
Quantum Cyber Appoints Veteran Distribution Executive Dennis Schnur as Head of U.S. Sales as Company Advances Toward Commercialization of Domestic Drone Production
August 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/25/3350341/0/en/quantum-cyber-appoints-veteran-distribution-executive-dennis-schnur-as-head-of-u-s-sales-as-company-advances-toward-commercialization-of-domestic-drone-production.html
See More Mainz Biomed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mainz Biomed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mainz Biomed and other key companies, straight to your email.

About Mainz Biomed

Mainz Biomed (NASDAQ:QUCY) B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

View Mainz Biomed Profile
Earnings Tools